Research Topics
Genomes and Genes | Jean BourhisSummaryAffiliation: Institut Gustave Roussy Country: France Publications
| Collaborators
|
Detail Information
Publications
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisJean Bourhis
Radiation Oncology Department, Institut Gustave Roussy, Villejuif, France
Lancet 368:843-54. 2006..Comparison of the different types of altered radiotherapy suggests that hyperfractionation has the greatest benefit...
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trialJean Bourhis
Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
Lancet Oncol 13:145-53. 2012..We aimed to assess the efficacy and safety of a combination of these approaches...
Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?J Bourhis
Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
Hematol Oncol Clin North Am 13:769-75, vii. 1999....
Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC)J Bourhis
Department of Radiation Oncology, Gustave Roussy Institute, 39 rue Camille Desmoulins, 94805 Villejuif, France
Semin Oncol 31:822-6. 2004..The two regimens are currently being tested in an ongoing randomized study and also being compared to moderately accelerated RT and concomitant CT...
[Larynx preservation: nonsurgical approaches]J Bourhis
Departement de Radiotherapie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Cancer Radiother 8:S24-8. 2004..Finally, larynx preservation is generally not proposed in patients with deeply infiltrating tumors and or tumor invading the cartilage or soft tissue in the neck (T4)...
Randomized trials of amifostine and radiotherapy: effect on survival?J Bourhis
Department of Radiotherapy, Institut Gustave Roussy, Villejuif, Cedex France
Semin Oncol 31:62-6. 2004..It will be also possible to study the effect(s) of amifostine in different tumor types...
New approaches to enhance chemotherapy in SCCHNJ Bourhis
Institut Gustave Roussy, Villejuif 94805, France
Ann Oncol 16:vi20-vi24. 2005..Promising activity has also been observed with a number of other EGFR inhibitors, both MAbs and tyrosine kinase inhibitors...
Redefining 'state of the art' in head and neck cancerJ Bourhis
Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif 94805, France
Ann Oncol 16:vi5-vi6. 2005
Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trialJean Bourhis
Institut Gustave Roussy, Radiation Oncology, Head and Neck Statistics Department, Villejuif, France
J Clin Oncol 24:2873-8. 2006....
Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neckJean Bourhis
Institut Gustave Roussy, Radiotherapie, Villejuif, France
J Clin Oncol 24:2866-72. 2006..This was an open, randomized, multicenter, phase I/II study to investigate the safety and tolerability of cetuximab in the first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN)...
[Biomodulation and radiotherapy]J Bourhis
Département de radiothérapie et unité propre de l enseignement supérieur UPRES EA 27 10, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Cancer Radiother 4:128s-133s. 2000..In addition, other promising ways to modulate radiation-induced response concern extracellular or tissue factors such as hypoxia and angiogenesis...
Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitationsJean Bourhis
Institut Gustave Roussy, Radiation Oncology and Statistic Departments, Villejuif, France
Curr Opin Oncol 16:215-9. 2004..This article provides an overview of randomized studies of altered fractionated radiotherapy (RT) in Head and Neck squamous cell carcinoma...
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trialJean Bourhis
Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
Radiother Oncol 100:56-61. 2011..The objective was to evaluate the efficacy of a strong increase of the dose-intensity of concomitant radio-chemotherapy (RT-CT) in patients with far advanced non metastatic HNSCC...
A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinomaJ Bourhis
Radiation Oncology, Head and Neck Surgery, Villejuif, France
Int J Radiat Oncol Biol Phys 46:1105-8. 2000..The aim of this study was to assess whether amifostine could minimize acute mucositis induced by a very accelerated irradiation regimen in patients with advanced head and neck squamous cell carcinoma (HNSCC)...
Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivoLaurence Maggiorella
, 94805 Villejuif, Cedex, France
Cancer Res 63:2513-7. 2003..In conclusion, we found a novel effect on DNA repair of the CDK inhibitor roscovitine, which acts as a radiosensitizer in vitro and in vivo in breast cancer cells lacking a functional p53...
The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastropheYungan Tao
UPRES EA27 10 Laboratoire Radiosensibilité des Tumeurs et Tissus Sains, Villejuif, France
Cell Cycle 8:3172-81. 2009..Altogether, these data support the contention that AZD1152 mediates radiosensitization in vivo by enhancing mitotic catastrophe, which can be used as a biomarker of treatment efficacy...
Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protectionValerie Haydont
UPRES EA 27 10, Radiosensibilite des tumeurs et tissus sains, Institut de Radioprotection et de Sûreté Nucléaire Institut Gustave Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 68:1471-82. 2007....
Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in ratsValerie Haydont
UPRES EA 27 10 Radiosensibilité des tumeurs et tissus sains, Institut de Radioprotection et de Sûreté Nucléaire Institut Gustave Roussy, Villejuif, France
Clin Cancer Res 13:5331-40. 2007..Among these new targets, we identified the Rho/ROCK pathway and thought to investigate whether pravastatin treatment inhibits Rho pathway activation and elicits an antifibrotic action...
Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protectionMonica Mangoni
Laboratoire UPRES EA 2710, Institut Gustave Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 74:1242-50. 2009....
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient dataStefan Michiels
Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
Lancet Oncol 10:341-50. 2009..This would allow a reduction in the duration and cost of the development of new treatments...
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasionAlexandre Kaliski
, Villejuif, France
Mol Cancer Ther 4:1717-28. 2005..This model could provide in vivo evidence of the antitumor efficacy of combining a MMP inhibitor with ionizing radiation to target radiation-induced invasion and angiogenesis...
Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma modelLaurence Maggiorella
, Institut Gustave-Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Anticancer Res 25:4357-62. 2005..These data suggested that Ritonavir could clinically improve the tumor response to radiation therapy, especially in head and neck carcinoma...
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient dataJean Bourhis
Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif Cedex, France
J Clin Oncol 29:2590-7. 2011..The aim of this meta-analysis was to evaluate the impact of amifostine on overall survival (OS) and progression-free survival (PFS) in patients treated with radiotherapy or chemoradiotherapy...
Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell linesAbdessamad Amine
, Institut Gustave Roussy, Villejuif, France
Radiat Res 166:600-10. 2006..This study showed that the combination of cidofovir with ionizing radiation has an antiangiogenic effect associated with VEGF inhibition subsequent to E6 inhibition and TP53 restoration...
Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinomaFrancois Janot
Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France
J Clin Oncol 26:5518-23. 2008..The Groupe d'Etude des Tumeurs de la Tête et du Cou and Groupe d'Oncologie Radiothérapie Tête Et Cou groups performed a randomized study to assess its efficacy...
Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritisCarine Strup-Perrot
, , 94805 Villejuif, France
Am J Physiol Gastrointest Liver Physiol 287:G875-85. 2004..This demonstrates that established fibrotic tissue is not scarred fixed tissue but is subjected to a dynamic remodeling process...
Current concepts of management in radiotherapy for head and neck squamous-cell cancerRenaud Mazeron
Department of Radiotherapy, Institute Gustave Roussy, 39 rue Camille Desmoulins, Villejuif 94805, France
Oral Oncol 45:402-8. 2009..Finally management of treatment related acute or late toxicity remains an important issue and in the last decade major achievements have been obtained in this field especially using intensity modulated radiotherapy (IMRT)...
Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas - stratification for postsalvage survivalHiang Khoon Tan
Department of Head and Neck Surgery, Institut de Cancerologie Gustave Roussy, Villejuif, France
Head Neck 32:139-47. 2010..Salvage surgery after concomitant chemoradiation therapy (CCRT) for patients with head and neck squamous cell carcinomas (HNSCC) is challenging because of its associated morbidity/mortality and the poor prognoses of these patients...
Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cellsAbdessamad Amine
Laboratoire UPRES EA 27 10 Radiosensibilité des Tumeurs et Tissus Sains, Institut Gustave Roussy Institut de Radioprotection et de Sureté Nucléaire, Villejuif, France
PLoS ONE 4:e5018. 2009..These data suggest a novel and highly translatable therapeutic approach to cervix cancer, by inhibition of adhesion and invasion of circulating HPV-positive tumor cells, using Cidofovir and/or ROCK inhibition...
Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpointsYungan Tao
UPRES EA27 10 Laboratoire Radiosensibilité des Tumeurs et Tissus Sains, University Paris Sud XI Kremlin Bicêtre and Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France
Cell Cycle 8:1196-205. 2009..Altogether these results suggest that Chir-124-mediated radiosensitization is profoundly influenced by the p53 and cell cycle checkpoint system...
Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation responseYohann Loriot
UPRES 27 10, Institut Gustave Roussy, Villejuif, France
Anticancer Res 30:3869-78. 2010..The present study evaluated the efficacy of combining BCL-2 ODN and radiation in small-cell lung cancers (SCLC) cell lines...
Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinomaStephane Temam
Department of Otorhinolaryngology-Head and Neck Surgery, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
Int J Radiat Oncol Biol Phys 62:1078-83. 2005..CONCLUSION: Salvage surgery for relapse after very accelerated radiotherapy for advanced HNSCC is infrequently feasible and is of limited survival benefit. It should be used only in carefully selected cases...
Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinomaStephane Temam
Department of Otorhinolaryngology Head and Neck Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
Head Neck 27:653-8. 2005..The aim of this study was to determine the rate of occult neck node metastasis and the surgical morbidity of patients after salvage surgery for local relapse after definitive radiotherapy...
[Concomitant chemoradiation in patients with cervix cancer]Christine Haie-Meder
Service de curiethérapie, Departement de Radiotherapie, Institut Gustave Roussy, rue Camille Desmoulins, 94800 Villejuif
Bull Cancer 92:1032-8. 2005..Future randomised trials should also aim to establish optimal chemotherapy regimens for combination with radiotherapy...
Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridizationMarie Catherine Vozenin-Brotons
Laboratoire UPRES EA 27 10 Radiosensibilité des Tumeurs et Tissus Sains, Institut Gustave Roussy Institut de Radioprotection et de Sureté Nucléaire, Villejuif, France
Radiat Res 161:299-311. 2004..e. the mucosa, the mesenchyme, and blood vessels. Functional studies will be necessary to validate the present results...
Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancerPierre Blanchard
Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
J Clin Epidemiol 64:985-92. 2011..Mixed treatment comparison (MTC) meta-analysis allows one to perform simultaneous inference regarding all treatments and select the best among them...
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patientsJean Pierre Pignon
Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
Radiother Oncol 92:4-14. 2009..However the heterogeneity of the results limited the conclusions and prompted us to confirm the results on a more complete database by adding the randomised trials conducted between 1994 and 2000...
Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patientsBerrin Pehlivan
Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
Acta Oncol 48:440-5. 2009..We aimed to evaluate whether a daily PI is worthwhile and we derived the Planning Target Volume (PTV) margins from the estimation of systematic and random errors...
BCR-ABL down-regulates the DNA repair protein DNA-PKcsE Deutsch
, Institut Gustave Roussy, Villejuif, France
Blood 97:2084-90. 2001..The down-regulation of DNA-PKcs was reversible in CD34(+) CML cells suggesting that this approach might offer a novel and powerful therapeutic strategy in this disease, especially to delay the blast crisis. (Blood. 2001;97:2084-2090)..
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinomaYungan Tao
Institute Gustave Roussy, Villejuif, France
Radiother Oncol 98:42-7. 2011..To determine the maximum tolerated dose (MTD) of oral cisplatin (CP Ethypharm®) in combination with radiotherapy in head and neck squamous cell carcinoma (HNSCC) and the recommended dose for phase II trials...
Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?Jean Bourhis
Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif 94805, France
Eur J Cancer 46:1979-89. 2010..Preliminary evidence suggests that cetuximab could be incorporated into induction management strategies. Taken together, these data support an important role for cetuximab in the treatment paradigm for locoregionally advanced SCCHN...
Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancerYungan Tao
Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
Acta Oncol 47:442-50. 2008..A long-term follow-up will be needed to evaluate potential late treatment complications related to the use of IMRT and the low or moderate irradiation dose level obtained in the pelvis and in the whole body...
Oral cavity squamous cell carcinoma in 260 patients aged 80years or moreCecile Ortholan
Department of Radiotherapy, Centre Antoine Lacassagne, Nice, France
Radiother Oncol 93:516-23. 2009..We report the experience of two French cancer centers in the treatment of oral cavity squamous cell carcinoma (SCC) in patients aged 80 years...
Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agentsNicolas Magne
Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
Cancer Metastasis Rev 27:737-50. 2008....
Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the ratSandra Torres
Radiosensibilité des Tumeurs et des Tissus Sains, UPRES EA 2710, Institut de Radioprotection et de Sûreté Nucléaire Institut Gustave Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 69:1563-71. 2007..The therapeutic potential of acute administration of glucagon-like peptide-2 (GLP-2) against acute and chronic intestinal injury was investigated in this study...
The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trialsNicolas Magne
Department of Radiotherapy, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94 805 Villejuif, France
Eur J Cancer 44:2133-43. 2008..Here we report all the different published clinical trials focusing on efficacy and toxicity in order to clarify and to summarise the present state-of-the-art of this particularly promising combination in solid tumour management...
Quantified relationship between cellular radiosensitivity, DNA repair defects and chromatin relaxation: a study of 19 human tumour cell lines from different originNicole Chavaudra
UPRES EA 2710, Institut Gustave-Roussy, 94805 Villejuif, France
Radiother Oncol 73:373-82. 2004..Four cell lines groups showing different DSB repair and/or chromatin impairments were defined. Cell lines exhibiting both DSB repair defect and chromatin relaxation are the most radiosensitive...
Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combinationPierre Mordant
UPRES 2710, Universite Paris XI, Institut Gustave Roussy, Villejuif, 94805 France
Mol Cancer Ther 9:358-68. 2010..The combination of RAF and mTOR inhibitors is effective for enhancing antitumoral effects in cells with deregulation of both RAS-RAF and PI3K, possibly through the cross-inhibition of 4E binding protein 1 and S6 protein...
[Locoregional recurrences of HNSCC: place of re-irradiations]Jean Bourhis
Radiothérapie et chirurgie cervico faciale, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex
Bull Cancer 91:871-3. 2004..Indeed, the feasibility of this approach has been shown, and may be associated with a curative potential in a relatively low proportion of these relapses...
Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an updateJean-Pierre Pignon
Biostatistics and Epidemiology Unit, Institut Gustave-Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 69:S112-4. 2007
Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectivesValerie Haydont
UPRES EA 27 10 Radiosensibilité des tumeurs et tissus sains, Institut Gustave Roussy Institut de Radioprotection et de Sureté Nucléaire, Villejuif, France
Radiother Oncol 76:219-25. 2005....
Individual patients' data meta-analyses in head and neck cancerJean Bourhis
Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
Curr Opin Oncol 19:188-94. 2007..The database included nearly 120 randomized trials, and about 25,000 patients, with a median follow-up of 6 years...
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cellsB Wen
, Institut Gustave Roussy, , France
Br J Cancer 85:2017-21. 2001..These results suggest that Tyrphostin AG 1024 could be used as a potential therapeutic agent in combination with irradiation...
Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinomaR De Crevoisier
, Institut Gustave-Roussy, Villejuif, France
Cancer 91:2071-6. 2001..These results prompted the authors to initiate a multicentric randomized trial that is ongoing (GETTEC-GORTEC 99-01) to evaluate the benefit of adjuvant radiochemotherapy in these types of patients...
Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial)Céline Bourgier
Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 81:1228-35. 2011..Nonetheless, the optimal radiation dose is not yet known. Here, we report feasibility and early toxicities of APBI delivering 40 Gy over 5 days, in a phase II trial...
Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapyPierre Graff
Department of Radiation Oncology, Alexis Vautrin Center, Vandoeuvre les Nancy, France
Int J Radiat Oncol Biol Phys 67:1309-17. 2007..To assess the benefit of intensity-modulated radiotherapy (IMRT) compared with conventional RT for the quality of life (QOL) of head and neck cancer survivors...
Hyperfractionated or accelerated radiotherapy for head and neck cancerBertrand Baujat
Head and Neck Surgery, Hopital Foch, 40 rue Worth, Suresnes, France, 92150
Cochrane Database Syst Rev 12:CD002026. 2010..Several trials have studied the role of altered fractionation radiotherapy in head and neck squamous cell carcinoma, but the effect of such treatment on survival is not clear...
Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancersRadhia M'kacher
Laboratoire de la Radiosensibilité des Tumeurs et des Tissus Sains, UPRES EA 27 10, Institut Gustave Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 68:465-71. 2007..This study was premised on the finding that telomere dysfunction and DNA repair pathways were related to many pathologic conditions...
Advances in radiotherapy of head and neck cancersYungan Tao
Department of Radiotherapy, Institute Gustave Roussy, Villejuif, France
Curr Opin Oncol 22:194-9. 2010..Radiation therapy plays a key role in the management of head and neck cancers (HNCs). We reviewed the recent advances in radiotherapy of HNCs and the role of imaging in treatment planning...
Radioprotective effect of amifostine in patients with head and neck squamous cell carcinomaJean Bourhis
Institut Gustave Roussy, , France
Semin Oncol 29:61-2. 2002..In conclusion, the experience obtained to date in HNSCC patients treated with radiotherapy supports the selective cytoprotective activity of amifostine to minimize radiation effects while apparently not diminishing tumor control...
Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cellsBixiu Wen
UPRES EA No 27 10, Radiosensibilité des tumeurs et des tissues sains, Institut Gustave Roussy, 94805 Villejuif Cedex, France
J Urol 170:2036-9. 2003..We examined the potential therapeutic effect of NS398, a selective cyclooxygenase-2 (COX-2) inhibitor, combined with irradiation on human prostate adenocarcinoma DU145 cells...
[Radiotherapy and targeted therapies in head and neck carcinomas and NSCLC]A Bruna
Departement de Radiotherapie, Institut Gustave Roussy, 94800 Villejuif, France
Bull Cancer 96:65-8. 2009..Particularly, their addition to the reference treatments that are chemo-radiotherapy is studied. The first clinical results will be detailed, as well as their biological explanation...
End points for new agents in induction chemotherapy for locally advanced head and neck cancersC Monnerat
Departments of Medicine, Head and Neck Surgery and Radiotherapy, Institut Gustave-Roussy, Villejuif, France
Ann Oncol 13:995-1006. 2002..Finally, we have examined the impact of new cytotoxic agents and present the promising results of new taxane-based combinations...
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphomaA Bennaceur
Department of Medicine, UPRES EA 27-10, Villejuif, France
Oncogene 22:7905-12. 2003..These findings could clinically be exploited to increase the dismal response rates of MCL patients to the current chemotherapy regimens...
Definitive radiotherapy for squamous cell carcinoma of the pyriform sinusPierre Blanchard
Institut Gustave Roussy, Villejuif, France Electronic address
Radiother Oncol 105:232-7. 2012..To report the long-term results after definitive radiotherapy (RT) for pyriform sinus squamous cell carcinoma (SCC)...
Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trialEtienne Bardet
Department of Radiation Oncology, Centre Régional de Lutte Contre le Cancer Nantes Atlantique René Gauducheau, Nantes, France
J Clin Oncol 29:127-33. 2011..To compare compliance with and efficacy of intravenous (IV) and subcutaneous (SC) amifostine for the treatment of patients undergoing radiotherapy for head and neck cancer...
Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancerMarkhaba Tukenova
L Institut National de la Santé et de la Recherche Médicale, Institut Gustave Roussy, 94805 Villejuif Cedex, France
J Clin Oncol 28:1308-15. 2010..The purpose of this study was to assess the role of treatment in long-term overall and cardiovascular mortality after childhood cancer...
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neckJean Pierre Pignon
Unit of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
Anticancer Drugs 15:331-40. 2004..We conclude that this improved survival might be due either to docetaxel's pharmacologic effect or to uncontrolled prognostic factors...
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour sitePierre Blanchard
Biostatistics and Epidemiology Department, Institut Gustave Roussy, Villejuif, France
Radiother Oncol 100:33-40. 2011..The magnitude of the benefit according to tumour site is unknown as well as their potential interactions with patient or trial characteristics...
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenograftsCyrus Chargari
Radiothérapie moléculaire, Universite Paris XI, Institut Gustave Roussy, Villejuif, France
Cancer Lett 312:209-18. 2011..Further investigations are warranted with regard to the molecular mechanisms underlying its actions and its dependency regarding p53 status...
Environmental, genetic, and molecular features of prostate cancerEric Deutsch
Laboratoire UPRES EA 27 10, Institut Gustave Roussy, Villejuif, France
Lancet Oncol 5:303-13. 2004..This transition also signals a substantial worsening of prognosis. Here, we review the most important findings in prostate carcinogenesis and the molecular anomalies associated with the androgen-refractory stage...
[Angiogenesis inhibitors and radiation therapy: concept and preliminary results]R Mazeron
UPRES EA2710, laboratoire de radiosensibilité des tumeurs et des tissus sains, Institut Gustave Roussy, Villejuif, France
Bull Cancer 96:299-310. 2009..Hence, further studies need to be conducted to assess toxicities, doses and sequences of the combination. Numerous of phases I and II clinical trials are ongoing and answers are awaited...
[Epidermal growth factor receptor (EGF) in head-and-neck cancers]J Bourhis
Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
Bull Cancer 94:F189-91. 2007..This suggests the potential interest of the combination between anti-EGFR drugs and cytotoxic agents, especially ionizing radiation with promising results obtained at the clinical level in locally advanced HNC...
n-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesisB Wen
, Institut Gustave Roussy, 39, rue Camille Desmoulins, , France
Br J Cancer 89:1102-7. 2003..The magnitude of the differential effect suggests that n-3 PUFAs need to be further investigated in the clinic...
[New strategies to interfere with radiation response: "biomodulation" of radiation therapy]E Deutsch
Laboratoire de radiosensibilité des tumeurs et des tissus sains UPRES EA27 10, Departement de Radiotherapie, Institut Gustave Roussy, Villejuif, France
Cancer Radiother 9:69-76. 2005..3) Strategies which are not targeted against the tumor but the microenvironment, especially angiogenesis. This type of approaches seems to be applicable independently of tumor intrinsic biologic related factors...
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiationS Vaganay-Juéry
Unité Propre de l Enseignement Supérieur Radiosensibilité humaine, UPRES, Villejuif, France
Br J Cancer 83:514-8. 2000..This modulation of DNA-PK activity was a rapid phenomenon occurring within the 2 h following low-dose radiation exposure. These data strongly suggest the implication of the DNA-PK repair complex in the HRS phenomenon...
The olivacine S16020 enhances the antitumor effect of ionizing radiation without increasing radio-induced mucositisL Maggiorella
, , Institut Gustave Roussy, 94805 Villejuif Cedex, France
Clin Cancer Res 7:2091-5. 2001..In conclusion, the combination of IR and S16020 seems promising to enhance antitumor activity without increasing deleterious effect in normal tissues and to provide the basis for a new radio-chemotherapy combination...
Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patientsBertrand Baujat
Institut Gustave-Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 64:47-56. 2006..CONCLUSION: Chemotherapy led to a small, but significant, benefit for overall survival and event-free survival. This benefit was essentially observed when chemotherapy was administered concomitantly with RT...
IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?Amaury Paumier
Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
Radiother Oncol 99:73-8. 2011....
Sensitivity to radiation and alkylating agent of peripheral lymphocytes and fibroblasts in a Hoyeraal-Hreidarsson syndrome patientRadhia M'kacher
Service de Pediatrie, Centre Hospitalier Universitaire de Besancon, Bescancon, France
Pediatr Hematol Oncol 20:651-6. 2003..The data suggest that conditioning regimens including TBI should not be used when a bone marrow transplantation procedure is planned in these patients...
Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expressionMarie Catherine Vozenin-Brotons
Laboratoire UPRES EA 27 10 Radiosensibilité des Tumeurs et Tissus Sains, Institut Gustave Roussy Institut de Radioprotection et de Sureté Nucléaire, Villejuif, France
Int J Radiat Oncol Biol Phys 56:561-72. 2003..To investigate the expression of a new fibrogenic cytokine the connective tissue growth factor (CTGF) in intestinal radiation fibrosis and to characterize the mesenchymal cell subtypes involved in CTGF synthesis and collagen deposition...
Botulinum toxin for radiation-induced facial pain and trismusDana M Hartl
Department of Otolaryngology Head and Neck Surgery, Institut Gustave Roussy, Villejuif, France
Otolaryngol Head Neck Surg 138:459-463. 2008..To report the efficacy of botulinum toxin A for radiation-induced pain, trismus, and masticator spasm in head and neck cancer...
Implications of learning effects for hospital costs of new health technologies: the case of intensity modulated radiation therapyJulia Bonastre
Gustave Roussy Institute, Villejuif, France
Int J Technol Assess Health Care 23:248-54. 2007..The impact of learning effects on the variability of costs of new health technologies in a prospective payment system (PPS) through the case of intensity modulated radiation therapy (IMRT) was studied...
[The cost of intensity modulated radiation therapy in head and neck cancers: results of the 2002 STIC study]M Julia Bonastre
Institut Gustave Roussy, Direction des études économiques, 39 rue Camille Desmoulin, 94805 Villejuif
Bull Cancer 93:1026-32. 2006..For 70 % of the patients, reimbursement did not offset the cost of treatment. A financial support for hospitals implementing the technique is essential during the whole learning period...
[Individual patient data meta-analyses in head and neck carcinoma: what have we learnt?]J P Pignon
Service de biostatistique et d épidémiologie, Département de Chirurgie Cervicofaciale, Departement de Radiotherapie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Cancer Radiother 9:31-6. 2005..The results showed a small but significant improvement in favor of altered fractionated RT for overall survival and local control with an absolute benefit at five years of 3 and 6%, respectively...
Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylationE Deutsch
Laboratoire UPRES EA No 27 10, Radiosensibilite des tumeurs et tissus sains, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
Br J Cancer 91:1735-41. 2004..Therefore, these data suggest that Tyrphostin AG1024 could represent the basis of a novel therapy for STI571 refractory CML...
[Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study]C Bourgier
Département d Oncologie Radiothérapie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94800 Villejuif, France
Cancer Radiother 14:718-26. 2010..Here, we report the original dosimetric results of this technique...
Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patientsR M'kacher
Department of Medicine, Institut Gustave Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 57:321-6. 2003..To study chromosomal abnormalities in 49 patients with Hodgkin's lymphoma (HL), before and after treatment and at several times during a 2-year period...
[Role and perspectives of sentinel node biopsy in head and neck tumors]G Mamelle
Département de Chirurgie Cervicofaciale, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France
Cancer Radiother 10:349-53. 2006..To evaluate the accuracy of sentinel node biopsy for assessing the neck status for those patients with squamous cell carcinoma T1T2N0 of oral cavity...
JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcomeR M'kacher
Cell and Environment, 88bis rue des Pyrénées, Paris, France
Ann Oncol 21:826-32. 2010..We investigated JCV and Epstein-Barr virus (EBV) status in peripheral blood lymphocytes (PBL) from 74 Hodgkin's lymphoma (HL) and 91 B-cell non-Hodgkin's lymphoma (B-NHL) patients...
Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152Y Tao
Laboratory UPRES EA27 10 Radiosensitivity of tumors and normal tissues, Villejuif, France
Oncogene 27:3244-55. 2008..Altogether, these data indicate that AZD1152 can radiosensitize tumor cell lines in vitro and in vivo, the fact that these effects are exacerbated in p53-deficient cancer cells is of potential interest for further clinical development...
Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomasF Dhermain
Department of Radiation Therapy, Institut Gustave Roussy, Villejuif, France
J Neurooncol 97:81-8. 2010..04 and 0.02, respectively. Different prognostic subgroups were identified, with 2-year PFS of 86%, 57%, and 19% for pts with no MVL, MVL without CE, and MVL with CE, respectively. MVL and CE seem to predict short-term outcome in ULGG pts...
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck CancerJ P Pignon
Department of Biostatistics and Epidemiology, Institut Gustav Roussy, Villejuif, France
Lancet 355:949-55. 2000..We did three meta-analyses of the impact of survival on chemotherapy added to locoregional treatment...
Radiotherapy in head and neck cancer in the elderly: a challengeJ P Metges
Department of Radiotherapy, Institut Gustave Roussy avenue Camille Desmoulins, 94805 Cedex, Villejuif, France
Crit Rev Oncol Hematol 34:195-203. 2000..However, specific trials concerning aged patients with head and neck cancer, quality of life and radiotherapy are warranted...
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]E Bardet
Departement de Radiotherapie, Centre Rene Gauducheau, Boulevard Jacques Monod, 44805 Nantes Saint Herblain, France
Bull Cancer 96:1013-28. 2009..The purpose of the present article was to evaluate indications, regimens, treatment modalities, and predictive factors of response to treatment in locally advanced squamous cell carcinoma of the head and neck (SCCHN)...
Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinomaJean Denis Légal
UPRES EA29 10, Institut Gustave Roussy, Villejuif, France
Int J Radiat Oncol Biol Phys 52:1186-95. 2002..Therefore, we tried to define their incidence in such patients, to determine an in vitro dose-effect relationship, and to correlate these data with clinical parameters...
Antiviral approaches for cancers related to Epstein-Barr virus and human papillomavirusB Abdulkarim
Departement de Radiotherapie, Institut Gustave Roussy, Villejuif, France
Lancet Oncol 2:622-30. 2001..These data provide the basis for a novel anticancer strategy to improve the therapeutic ratio in virus-related cancers, which needs to be further investigated for clinical applications...
Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cellsY Tao
Laboratory UPRES EA27 10 Radiosensitivity of tumors and normal tissues, University Paris XI, Institut Gustave Roussy, Villejuif, France
Br J Cancer 97:1664-72. 2007..These results demonstrate that PHA680632 in association with radiation leads to an additive effect in cancer cells, especially in the p53-deficient cells, but does not act as a radiosensitiser in vitro or in vivo...
Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expressionC Bourgier
Laboratoire UPRES EA 27-10, , PR1, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France
Gut 54:336-43. 2005..It suggests that specific inhibition of Rho kinase may be a promising approach for the development of antifibrotic therapies...
BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiationY Loriot
Institut Gustave Roussy, UPRES 27 10, 39 rue Camille Desmoulins, 94800 Villejuif, France
Br J Cancer 103:347-53. 2010....
[Building Clinical Target Volume in laryngeal cancers using knowledge about modes of invasion of each location]F J Bidault
, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif, France
Cancer Radiother 9:271-9. 2005..Then illustrated examples on Computed Tomography are provided. This delineation approach appears to be useful with 3D-CRT and IMRT for adapting dose delivery to the complex spread of laryngeal cancer...
